For its effect on MetS risk, a multiple-phenotype GWAS has identified rs7107152 and rs1242229 SNPs of SIDT2 to be associated with metabolic syndrome risk in the Korean population (Marston et al., 2021), increasing HDL and triglyceride levels among metabolic syndrome-component traits. This evidence concerns the gene SIDT2 and metabolic syndrome.